1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017

Please note: The report is Chinese version. It will provide the English version in two business days

Chemical pharmaceutical is the main industry of China pharmaceutical market, occupying a pivotal position in the pharmaceutical industry. With the improvement of the national economical development and residents’ living standards, the chemical pharmaceutical market gradually expands and the position gradually improves in China. Seen from the industrial gross output value and growth rate, the proportion of industrial output value in GDP has kept increasing with a rapid growth since 2005. In the long run, because China chemical pharmaceutical industry is still in a relatively backward position, especially the R&D capacities of the original study medicine, in order to ensure medication needs of the broad masses of people and improve the international position of chemical pharmaceutical industry, it still gives strong support to the development of chemical pharmaceutical industry. On the other hand, the domestic demand for drugs still keeps increasing in China. With comprehensive consideration, the position of chemical pharmaceutical industry in the China national economy is expected to further enhance.

The chemical pharmaceutical industry has kept a high level and steady growth rate for recent 6 years, sales revenue of 2011 reaching CNY 715.516 billion and 23.40% growth rate, which is mainly influenced by the good economical development of China, rigid demand of an aging population, the introduction of a series of medical reform policy including increase in the proportion of health insurance reimbursement etc. In 2012, the sales revenue of chemical pharmaceutical was CNY 831.3 billion with 18.98% year-on –year growth.

In 2012, the chemical pharmaceutical industry still run high development trend basing on over 90% of production and marketing rate. It is predicted that this trend is hard to make immediate changes in short terms. It is predicted that the production capacity of the future chemical pharmaceutical industry will continuously enhance and the gross value of industrial output is expected to keep a higher growth. The production capacity of China pharmaceutical companies will also gradually enhance with the expansion of pharmaceutical market. Meanwhile, the chemical pharmaceutical industry face changes of development model and adjustments of industrial structure. For pharmaceutical companies, updating and restructuring is the only way to become bigger and stronger.

The implementation of the 12th- Five-Year plan of pharmaceutical industry points out the direction for the future development of chemical pharmaceutical industry. As the major industry of the emerging strategic development of the national economy in China, chemical pharmaceutical industry has more developing chances. Over the next 10 years, chemical pharmaceutical industry still face the development chances focusing on the drug price adjustment, structure adjustment, industry consolidation and restructuring and changes of development model. Supporting products, projects and enterprises which are in line with industry trends, will have good investment returns.

Table Of Contents

Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017
Table of Contents

1. China Chemical Pharmaceutical Overview
1.1 Definition of Chemical Pharmaceutical
1.1.1 Classification and Definition of Industry
1.1.2 Industry Status
1.2 Periodic Analysis of Chemical Pharmaceutical Industry

2. Development Overview of Foreign Chemical Pharmaceutical Market
2.1 Market Analysis of Global Chemical Pharmaceutical
2.1.1 Global Market
2.1.2 Development Forecast of Global Market
2.2 Market Overview of Major Countries in Asia
2.3 Market Overview of Major Countries in Europe
2.4 Market Overview of Major Countries in America

3. Environment Analysis of China Chemical Pharmaceutical
3.1 Development Environment of China Economy
3.1.1 Economy Development
3.1.2 GDP Analysis of China
3.1.3 Investment in Fixed Assets
3.1.4 Total Imports and Exports and Growth Rate
3.2 Industrial Related Policy and Standards
3.3 Technical Environment of China Chemical Pharmaceutical

4. Operation of Chemical Pharmaceutical Industry, 2011-2012
4.1 Supply of Chemical Pharmaceutical
4.1.1 Total Supply and Growth
4.1.2 Changes of Supply Structure
4.2 Demand Analysis and Forecast of Chemical Pharmaceutical
4.2.1 Demand and Growth
4.2.2 Changes of Demand Structure
4.3 Market Analysis and Forecast of Chemical Pharmaceutical
4.3.1 Analysis and Forecast of Supply and Demand Balance
4.3.2 Analysis and Forecast of Price Changes
4.4 Financial Indicators of Chemical Pharmaceutical Industry
4.4.1 Profitability
4.4.2 Operation Ability
4.4.3 Debt Paying Ability

5. China Chemical Pharmaceutical Market Segments Status Quo
5.1 Vitamins
5.2 Antibiotics
5.3 Antipyretic Analgesics
5.4 Hormones
5.5 Anti-tumors

6. Import and Export of China Chemical Pharmaceutical
6.1 Import and Export Features of Chemical Pharmaceutical
6.2 Import Analysis
6.3 Export Analysis

7. Competition Pattern of China Chemical Pharmaceutical Industry
7.1 Analysis of Porter's Five Forces Model
7.1.1 Bargaining Power of Upstream Suppliers
7.1.2 Increased Competition among Existing Enterprises in the Industry
7.1.3 Bargaining Power of Downstream Users
7.1.4 Threat of New Entrants
7.1.5 Threat of Substitutes to Chemicals
7.2 Industry Current Competition Features
7.3 Industry International Competitiveness Factor Analysis

8. Analysis of Major Chemical Pharmaceutical Enterprises in China
8.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
8.1.1 Company Profile
8.1.2 Products and Advantages
8.1.3 Business Performance
8.1.4 Market Development Strategy
8.2 North China Pharmaceutical Company Ltd.
8.2.1 Company Profile
8.2.2 Products and Advantages
8.2.3 Business Performance
8.2.4 Market Development Strategy
8.3 Hisun Pharmaceutical Co. Ltd.
8.3.1 Company Profile
8.3.2 Products and Advantages
8.3.3 Business Performance
8.3.4 Market Development Strategy
8.4 Kelun Pharmaceutical Co. Ltd.
8.4.1 Company Profile
8.4.2 Products and Advantages
8.4.3 Business Performance
8.4.4 Market Development Strategy
8.5 Heng Rui Medicine Co. Ltd.
8.5.1 Company Profile
8.5.2 Products and Advantages
8.5.3 Business Performance
8.5.4 Market Development Strategy

9. Investment Risk of Chemical Pharmaceutical Industry
9.1 Analysis of Industry Investment Environment
9.1.1 Investment Structure Features
9.1.2 Merger and Reorganization
9.2 Industry Investment Barriers
9.2.1 Barriers to Entry
9.2.2 Exit Barriers
9.2.3 Access Conditions
9.3 Industry Investment Risk
9.3.1 Economic Environment Risk
9.3.2 Policy Environment Risk
9.3.3 Market Supply Demand Risk
9.3.4 Other Risk

10. Future Development Forecast of China Chemical Pharmaceutical
10.1 Future Development Forecast of Chemical Pharmaceutical Industry
10.2 Demand Forecast of Chemical Pharmaceutical Industry
10.3 Investment Advice

Companies Mentioned

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
North China Pharmaceutical Company Ltd.
Hisun Pharmaceutical Co. Ltd.
Kelun Pharmaceutical Co. Ltd.
Heng Rui Medicine Co. Ltd.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.